Last week, Moderna announced that it has received approval from the Food and Drug Administration (FDA) for the development of an mRNA vaccine for respiratory syncytial virus (RSV).
A censored study published by the National Institutes of Health (NIH) found that mRNA vaccines potentially alter the DNA of recipients and their offspring.
A study from the U.S. Centers for Disease Control and Prevention (CDC) found that children who received an original COVID-19 vaccine have little protection...
A recent study published in the medical journal Cureus found that 27.11% of those who received COVID-19 mRNA vaccines in Saudi Arabia had "cardiac complications."
Moderna recently announced that it is developing more mRNA vaccines targeting Epstein-Barr virus (EBV), Varicella-zoster virus (VZV, chickenpox, and shingles), and Norovirus.
